| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 3980 |
| 1 | ADALIMUMAB | 1070 |
| 2 | NALTREXONE | 912 |
| 3 | INTERFERON BETA-1A | 625 |
| 4 | METHOTREXATE SODIUM | 617 |
| 5 | METHOTREXATE | 616 |
| 6 | DUPILUMAB | 491 |
| 7 | GLATIRAMER ACETATE | 399 |
| 8 | ERGOCALCIFEROL | 337 |
| 9 | GABAPENTIN | 256 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FESTUCA ELATIOR | 2 | 0.4000 |
| 1 | LIDOCAINE HCL 0.5% | 2 | 0.2857 |
| 2 | LIDOCAINE HCL 5% | 2 | 0.2857 |
| 3 | DEOXYCHOLIC ACID | 86 | 0.0368 |
| 4 | NALTREXONE | 912 | 0.0294 |
| 5 | TUBERCULIN PURIFIED PROTEIN DERIVATIVE | 42 | 0.0223 |
| 6 | CYNODON DACTYLON | 2 | 0.0211 |
| 7 | SETMELANOTIDE | 5 | 0.0175 |
| 8 | DEGARELIX | 93 | 0.0174 |
| 9 | GLATIRAMER ACETATE INJECTION | 71 | 0.0151 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 4051 |
| 1 | Interferon beta [EPC] | 659 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 602 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 592 |
| 4 | Interleukin-4 Receptor alpha Antagonist [EPC] | 491 |
| 5 | GLP-1 Receptor Agonist [EPC] | 423 |
| 6 | Corticosteroid [EPC] | 414 |
| 7 | Vitamin C [EPC] | 381 |
| 8 | Insulin Analog [EPC] | 361 |
| 9 | Provitamin D2 Compound [EPC] | 337 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytolytic Agent [EPC] | 86 | 0.0368 |
| 1 | Skin Test Antigen [EPC] | 42 | 0.0223 |
| 2 | Melanocortin 4 Receptor Agonist [EPC] | 5 | 0.0175 |
| 3 | Interleukin-5 Antagonist [EPC] | 10 | 0.0145 |
| 4 | PCSK9 Inhibitor [EPC] | 323 | 0.0125 |
| 5 | Phenylalanine Metabolizing Enzyme [EPC] | 101 | 0.0119 |
| 6 | Provitamin D2 Compound [EPC] | 337 | 0.0113 |
| 7 | Adrenocorticotropic Hormone [EPC] | 10 | 0.0112 |
| 8 | Complement Factor D Inhibitor [EPC] | 3 | 0.0097 |
| 9 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 90 | 0.0087 |